International Patent: NOVEL ALLOSTERIC TRKA INHIBITOR, AND COMPOSITION CONTAINING SAME AS ACTIVE COMPONENT FOR PREVENTING OR TREATING PAIN DISORDERS

GENEVA, July 27 -- MOTHER"S PHARMACEUTICAL CO.,LTD. filed a patent application (KR2026/000941) for “NOVEL ALLOSTERIC TRKA INHIBITOR, AND COMPOSITION CONTAINING SAME AS ACTIVE COMPONENT FOR PREVENTING OR TREATING PAIN DISORDERS”. With publication no. WO/2026/155575, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07D 231/40

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....